Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2008-07-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.0801414105PMID 18641127PMCID PMC2492511
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis.

  2007influential reference
• Systemic sclerosis: a prototypic multisystem fibrotic disorder.

  2007cited by this paper
• The role of CXC chemokines in pulmonary fibrosis.

  2007cited by this paper
• Simultaneous generation of fra‐2 conditional and fra‐2 knock‐out mice

  2007cited by this paper
• Does current knowledge explain the pathogenesis of idiopathic pulmonary fibrosis? A perspective.

  2007cited by this paper
• Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots.

  2007cited by this paper
• The myofibroblast: one function, multiple origins.

  2007cited by this paper
• Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis.

  2006cited by this paper
• Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix

  2006cited by this paper
• IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis.

  2006cited by this paper
• Liver X Receptor Agonists Inhibit Cytokine-Induced Osteopontin Expression in Macrophages Through Interference With Activator Protein-1 Signaling Pathways

  2005cited by this paper
• Up-Regulation and Profibrotic Role of Osteopontin in Human Idiopathic Pulmonary Fibrosis

  2005cited by this paper
• Heterogeneous Remodeling of Lung Vessels in Idiopathic Pulmonary Fibrosis

  2005influential reference
• Fos/AP‐1 proteins in bone and the immune system

  2005cited by this paper
• Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.

  2004cited by this paper
• Altered bleomycin-induced lung fibrosis in osteopontin-deficient mice.

  2004cited by this paper
• Early Growth Response Gene 1–mediated Apoptosis Is Essential for Transforming Growth Factor β1–induced Pulmonary Fibrosis

  2004cited by this paper
• AP-1: a double-edged sword in tumorigenesis

  2003cited by this paper
• AP-1 Is Involved in UTP-Induced Osteopontin Expression in Arterial Smooth Muscle Cells

  2003cited by this paper
• Dual Roles of IL-4 in Lung Injury and Fibrosis1

  2003cited by this paper
• Inhibitory Effects of Novel AP-1 Decoy Oligodeoxynucleotides on Vascular Smooth Muscle Cell Proliferation In Vitro and Neointimal Formation In Vivo

  2002cited by this paper
• Osteopontin Transcription in Aortic Vascular Smooth Muscle Cells Is Controlled by Glucose-regulated Upstream Stimulatory Factor and Activator Protein-1 Activities*

  2002cited by this paper
• Osteopontin Plays an Important Role in the Development of Medial Thickening and Neointimal Formation

  2002cited by this paper
• Histopathological approach to patterns of interstitial pneumonia in patient with connective tissue disorders.

  2002influential reference
• Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy

  2001cited by this paper
• Lung interleukin-4 gene expression in a murine model of bleomycin-induced pulmonary fibrosis.

  2001cited by this paper
• AP-1 in mouse development and tumorigenesis

  2001cited by this paper
• Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1

  2000cited by this paper
• Overexpression of ΔFosB transcription factor(s) increases bone formation and inhibits adipogenesis

  2000cited by this paper
• Morphometric analysis of insulin-like growth factor-I localization in lung tissues of patients with idiopathic pulmonary fibrosis.

  1998cited by this paper
• Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.

  1998influential reference
• Overexpression of fra-2 in transgenic mice perturbs normal eye development

  1998cited by this paper
• Immediate-early gene expression in response to hypertrophic and proliferative stimuli in pulmonary arterial smooth muscle cells.

  1994cited by this paper
• Osteoblasts are target cells for transformation in c-fos transgenic mice

  1993cited by this paper

• A mechanomimetic model of skin fibrosis.

  2026cites this paper
• FOSL2 drives acute myeloid leukemogenesis through suppression of ERAD-induced proteostatic collapse.

  2026cites this paper
• Spatial transcriptomics reveals coordinated endothelial and epithelial activator protein-1 activation in CLAD.

  2026cites this paper
• Antibiotic-induced microbiota depletion impairs the pro-regenerative response to a biological scaffold in mice

  2025cites this paper
• Immune mediated inflammatory diseases: moving from targeted biologic therapy, stem cell therapy to targeted cell therapy

  2025cites this paper
• Targeting Type-2 Inflammation in Pulmonary Hypertension: Lessons from a Novel Model.

  2025cites this paper
• Molecular Pathogenesis of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: A Narrative Review

  2025cites this paper
• Corydalis decumbens and tetrahydropalmatrubin inhibit macrophages inflammation to relieve rheumatoid arthritis by targeting Fosl2.

  2025cites this paper
• Antibiotic-induced microbiota depletion impairs the proregenerative response to a biological scaffold.

  2025cites this paper
• Pulmonary vascular remodeling in Fra-2 transgenic mice is driven by type 2 inflammation and accompanied by pulmonary vascular hyperresponsiveness.

  2025cites this paper
• FAPI Tracer en Vogue: Evaluating [68Ga]Ga-DATA5m.SA.FAPi for Molecular Imaging of Pulmonary Fibrosis

  2025influential citation
• Loss of ALK3 Ameliorates Acute but Aggravates Chronic Lung Inflammation In Vivo

  2025cites this paper
• Transcriptional signatures of endothelial cells shape immune responses in cardiopulmonary health and disease

  2025cites this paper
• Single cell transcriptomics in a treatment-segregated cohort exposes a STAT3-regulated therapeutic gap in idiopathic pulmonary fibrosis

  2025cites this paper
• Integrated bioinformatics analysis screened the key genes and pathways of idiopathic pulmonary fibrosis

  2025cites this paper
• Machine learning analysis of FOSL2 and RHoBTB1 as central immunological regulators in knee osteoarthritis synovium

  2025cites this paper
• Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target.

  2024cites this paper
• The siRNA-mediated knockdown of AP-1 restores the function of the pulmonary artery and the right ventricle by reducing perivascular and interstitial fibrosis and key molecular players in cardiopulmonary disease

  2024cites this paper
• Fosl2 Deficiency Predisposes Mice to Osteopetrosis, Leading to Bone Marrow Failure.

  2024cites this paper
• Effect of Ritanserin and Duloxetine on the Gene Expression of Primary Aniridia and Healthy Human Limbal Stromal Cells, In Vitro

  2024cites this paper
• Ailanthone ameliorates pulmonary fibrosis by suppressing JUN-dependent MEOX1 activation

  2024cites this paper
• Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: From Bedside to Bench and Back Again

  2024cites this paper
• Integrated multiomic analysis identifies TRIP13 as a mediator of alveolar epithelial type II cell dysfunction in idiopathic pulmonary fibrosis

  2024cites this paper
• Therapeutic effects of MEL-dKLA by targeting M2 macrophages in pulmonary fibrosis.

  2024cites this paper
• Progress in the Study of Fra-2 in Respiratory Diseases

  2024influential citation
• A mouse model of progressive lung fibrosis with cutaneous involvement induced by a combination of oropharyngeal and osmotic minipump bleomycin delivery

  2024cites this paper
• Pathogenesis of interstitial lung disease in systemic sclerosis

  2024cites this paper
• Molecular Features and Stages of Pulmonary Fibrosis Driven by Type 2 Inflammation.

  2023cites this paper
• ATRA ameliorates fibrosis by suppressing the pro-fibrotic molecule Fra2/AP-1 in systemic sclerosis.

  2023cites this paper
• Activating Protein-1 (AP-1): A Promising Target for the Treatment of Fibrotic Diseases.

  2023cites this paper
• High‐resolution transcriptomic and epigenetic profiling identifies novel regulators of COPD

  2023influential citation
• The Plastic Interplay between Lung Regeneration Phenomena and Fibrotic Evolution: Current Challenges and Novel Therapeutic Perspectives

  2023cites this paper
• FOSL2 promotes intertumoral infiltration of T cells and increases pathological complete response rates in locally advanced rectal cancer patients.

  2023cites this paper
• Heterogeneous response to TGF-β1/3 isoforms in fibroblasts of different origins: implications for wound healing and tumorigenesis

  2023cites this paper
• Trypanosoma cruzi dysregulates expression profile of piRNAs in primary human cardiac fibroblasts during early infection phase

  2023cites this paper
• Searching for an Animal Model with Clinical Features of Scleroderma

  2023cites this paper
• SPARC is a decoy counterpart for c‑Fos and is associated with osteoblastic differentiation of bone marrow stromal cells by inhibiting adipogenesis

  2023cites this paper
• Macrophage Implication in IPF: Updates on Immune, Epigenetic, and Metabolic Pathways

  2023influential citation
• FOSL2 participates in renal fibrosis via SGK1-mediated epithelial-mesenchymal transition of proximal tubular epithelial cells

  2023cites this paper
• Effects of B Cell Depletion by CD19‐Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic Sclerosis

  2023cites this paper
• The vascular perspective on acute and chronic lung disease

  2023cites this paper
• Targeting Wnt-ß-Catenin-FOSL Signaling Ameliorates Right Ventricular Remodeling

  2023cites this paper
• The AP-1 transcription factor Fosl-2 drives cardiac fibrosis and arrhythmias under immunofibrotic conditions

  2023cites this paper
• Role of Fra-2 in cancer

  2023cites this paper
• NF-κB drives epithelial-mesenchymal mechanisms of lung fibrosis in a translational lung cell model

  2022cites this paper
• High-resolution transcriptomic and epigenetic profiling identifies novel regulators of COPD phenotypes in human lung fibroblasts

  2022cites this paper
• Fra-2 Is a Dominant Negative Regulator of Natural Killer Cell Development

  2022cites this paper
• Emerging therapies: The potential roles SGLT2 inhibitors, GLP1 agonists, and ARNI therapy for ARNI pulmonary hypertension

  2022cites this paper
• Pirfenidone exacerbates Th2-driven vasculopathy in a mouse model of SSc-ILD.

  2022cites this paper
• The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure

  2022cites this paper
• Efficacy and safety of abatacept for interstitial lung disease associated with antisynthetase syndrome: a case series.

  2022cites this paper
• Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models

  2022cites this paper
• What is hidden behind a pulmonary hypertensive, fibrotic and inflammatory phenotype?

  2022cites this paper
• Establishment of a humanized animal model of systemic sclerosis in which T helper-17 cells from patients with systemic sclerosis infiltrate and cause fibrosis in the lungs and skin

  2022cites this paper
• FOSL2 deficiency delays nonalcoholic steatohepatitis progression by regulating LY6D-mediated NLRP3 activation

  2022cites this paper
• Identification of circular RNA biomarkers for Pien Tze Huang treatment of CCl4-induced liver fibrosis using RNA-sequencing

  2022cites this paper
• Alternatively activated macrophages promote airway inflammation through JAK3–STAT5–Fra2 in asthma

  2022cites this paper
• The Fra-1: Novel role in regulating extensive immune cell states and affecting inflammatory diseases

  2022cites this paper
• Myofibroblast dedifferentiation proceeds via distinct transcriptomic and phenotypic transitions

  2021cites this paper
• Ticagrelor Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats by Inhibition of TGF-β1/Smad3 and PI3K/AKT/mTOR Pathways.

  2021cites this paper
• Nucleolar localization of c‐Jun

  2021cites this paper
• Syndecan-1 shedding by meprin β impairs keratinocyte adhesion and differentiation in hyperkeratosis.

  2021cites this paper
• Integrated expression profiles of mRNA and miRNA in a gerbil model of fatty liver fibrosis treated with exenatide.

  2021cites this paper
• Pulmonary fibrosis in Fra-2 transgenic mice is associated with decreased numbers of alveolar macrophages and increased susceptibility to pneumococcal pneumonia.

  2021cites this paper
• Chromatin Velocity reveals epigenetic dynamics by single-cell profiling of heterochromatin and euchromatin

  2021cites this paper
• Identification of a distal RXFP1 gene enhancer with differential activity in fibrotic lung fibroblasts involving AP-1

  2021cites this paper
• Heart Failure with Preserved Ejection Fraction and Cardiomyopathy: an Under-recognized Complication of Systemic Sclerosis

  2021cites this paper
• Identification of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity

  2021cites this paper
• Collagen VI as a driver and disease biomarker in human fibrosis

  2021cites this paper
• Sustained mechanical tension governs fibrogenic activation of tendon stromal cells in systemic sclerosis

  2021cites this paper
• Single-nuclear transcriptomics reveals diversity of proximal tubule cell states in a dynamic response to acute kidney injury

  2021cites this paper
• Mouse Models of Skin Fibrosis.

  2021cites this paper
• The effect of nintedanib versus mycophenolate mofetil in the Fra2 mouse model of systemic sclerosis-associated interstitial lung disease.

  2021cites this paper
• Targeting monocytes/macrophages in fibrosis and cancer diseases: Therapeutic approaches.

  2021cites this paper
• The multifaceted problem of pulmonary arterial hypertension in systemic sclerosis.

  2021cites this paper
• Is the Macrophage Phenotype Determinant for Fibrosis Development?

  2021cites this paper
• FOSL2 Is Involved in the Regulation of Glycogen Content in Chicken Breast Muscle Tissue

  2021cites this paper
• PDGFRα and αSMA mark two distinct mesenchymal cell populations involved in parenchymal and vascular remodeling in pulmonary fibrosis

  2020cites this paper
• The AP1 Transcription Factor Fosl2 Promotes Systemic Autoimmunity and Inflammation by Repressing Treg Development.

  2020cites this paper
• Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts

  2020cites this paper
• Identification of drugs targeting multiple viral and human proteins using computational analysis for repurposing against COVID-19

  2020cites this paper
• Pathogenesis of systemic sclerosis associated interstitial lung disease

  2020cites this paper
• A pre‐investigational new drug study of lung spheroid cell therapy for treating pulmonary fibrosis

  2020cites this paper
• Identi�cation of drugs targeting multiple viral and human proteins using computational analysis for repurposing against COVID-19

  2020cites this paper
• Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease

  2020cites this paper
• Activated KCNQ1 channel promotes fibrogenic response in hereditary gingival fibromatosis via clustering and activation of Ras.

  2020cites this paper
• IL-1 receptor blockade skews inflammation towards Th2 in a mouse model of systemic sclerosis

  2019cites this paper
• Loss of LRP1 promotes acquisition of contractile-myofibroblast phenotype and release of active TGF-β1 from ECM stores.

  2019cites this paper
• Antifibrotic Potential of MiR-335-3p in Hereditary Gingival Fibromatosis

  2019cites this paper
• Transcription factor Fra-2 and its emerging role in matrix deposition, proliferation and inflammation in chronic lung diseases.

  2019cites this paper
• Nintedanib: New indication for systemic sclerosis-associated interstitial lung disease

  2019cites this paper
• Role of linc00174/miR-138-5p (miR-150-5p)/FOSL2 Feedback Loop on Regulating the Blood-Tumor Barrier Permeability

  2019cites this paper
• Fos-related antigen-1 transgenic mouse as a model for systemic sclerosis: A potential role of M2 polarization

  2019cites this paper
• Transition from normal to cancerous cell by precancerous niche (PCN) induced chronic cell-matrix stress

  2019cites this paper
• Fra-2-expressing macrophages promote lung fibrosis in mice.

  2019influential citation
• Cardiac phenotype in mouse models of systemic autoimmunity

  2019cites this paper
• The immunopathology of lung fibrosis: amphiregulin-producing pathogenic memory T helper-2 cells control the airway fibrotic responses by inducing eosinophils to secrete osteopontin

  2019cites this paper
• TGFβ signaling and the control of myofibroblast differentiation: Implications for chronic inflammatory disorders

  2018cites this paper
• Vascular Mechanisms of Systemic Sclerosis

  2018cites this paper
• Bovine Mastitis Resistance: Novel Quantitative Trait Loci and the Role of Bovine Mammary Epithelial Cells

  2018cites this paper